Tenet Healthcare Corp Financials

THC

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Tenet Healthcare Corp (THC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 55/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Tenet Healthcare Corp has an operating margin of 16.5%, meaning the company retains $16 of operating profit per $100 of revenue. This strong profitability earns a score of 82/100, reflecting efficient cost management and pricing power. This is down from 28.8% the prior year.

Growth

Tenet Healthcare Corp's revenue grew a modest 3.1% year-over-year to $21.3B. This slow but positive growth earns a score of 37/100.

Leverage

Tenet Healthcare Corp has elevated debt relative to equity (D/E of 3.10), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Tenet Healthcare Corp's current ratio of 1.76 indicates adequate short-term liquidity, earning a score of 50/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Tenet Healthcare Corp has a free cash flow margin of 11.9%, earning a moderate score of 59/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

100

Tenet Healthcare Corp earns a strong 56.1% return on equity (ROE), meaning it generates $56 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100. This is down from 97.4% the prior year.

Altman Z-Score Grey Zone

2.03

Tenet Healthcare Corp scores 2.03, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Neutral

6/9

Tenet Healthcare Corp passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.50x

For every $1 of reported earnings, Tenet Healthcare Corp generates $1.50 in operating cash flow ($3.5B OCF vs $2.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

4.3x

Tenet Healthcare Corp earns $4.3 in operating income for every $1 of interest expense ($3.5B vs $821.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Revenue

$21.3B

YoY+3.1%

5Y CAGR+3.9%

Tenet Healthcare Corp generated $21.3B in revenue in fiscal year 2025. This represents an increase of 3.1% from the prior year.

EBITDA

$4.4B

YoY-35.5%

5Y CAGR+9.0%

10Y CAGR+8.8%

Tenet Healthcare Corp's EBITDA was $4.4B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 35.5% from the prior year.

Free Cash Flow

$2.5B

YoY+126.7%

5Y CAGR-2.5%

10Y CAGR+30.0%

Tenet Healthcare Corp generated $2.5B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 126.7% from the prior year.

Net Income

$2.4B

YoY-41.8%

5Y CAGR+25.2%

10Y CAGR+40.7%

Tenet Healthcare Corp reported $2.4B in net income in fiscal year 2025. This represents a decrease of 41.8% from the prior year.

EPS (Diluted)

$15.49

YoY-52.6%

5Y CAGR+32.8%

Tenet Healthcare Corp earned $15.49 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 52.6% from the prior year.

Cash & Debt

$2.9B

YoY-4.5%

5Y CAGR+3.3%

10Y CAGR+23.3%

Tenet Healthcare Corp held $2.9B in cash against $13.1B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

87M

YoY-8.6%

5Y CAGR-3.9%

10Y CAGR-1.2%

Tenet Healthcare Corp had 87M shares outstanding in fiscal year 2025. This represents a decrease of 8.6% from the prior year.

Gross Margin

N/A

Operating Margin

16.5%

YoY-12.4pp

5Y CAGR+5.2pp

Tenet Healthcare Corp's operating margin was 16.5% in fiscal year 2025, reflecting core business profitability. This is down 12.4 percentage points from the prior year.

Net Margin

11.1%

YoY-8.5pp

5Y CAGR+6.8pp

Tenet Healthcare Corp's net profit margin was 11.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 8.5 percentage points from the prior year.

Return on Equity

56.1%

YoY-41.3pp

5Y CAGR-2686.8pp

10Y CAGR+44.8pp

Tenet Healthcare Corp's ROE was 56.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 41.3 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

$1.4B

YoY+106.3%

10Y CAGR+42.6%

Tenet Healthcare Corp spent $1.4B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 106.3% from the prior year.

Capital Expenditures

$1.0B

YoY+8.5%

5Y CAGR+13.3%

10Y CAGR+1.8%

Tenet Healthcare Corp invested $1.0B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 8.5% from the prior year.

THC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$21.3B+3.1%	$20.7B+0.5%	$20.6B+7.2%	$19.2B-1.6%	$19.5B+10.5%	$17.6B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	$3.5B-41.1%	$6.0B+137.3%	$2.5B+7.6%	$2.3B-18.7%	$2.9B+44.3%	$2.0B
Interest Expense	$821.0M-0.6%	$826.0M-8.3%	$901.0M+1.2%	$890.0M-3.6%	$923.0M-8.0%	$1.0B
Income Tax	$433.0M-63.4%	$1.2B+286.9%	$306.0M-11.0%	$344.0M-16.3%	$411.0M+523.7%	-$97.0M
Net Income	$2.4B-41.8%	$4.1B+210.0%	$1.3B+31.0%	$1.0B-32.2%	$1.5B+92.2%	$768.0M
EPS (Diluted)	$15.49-52.6%	$32.70+472.7%	$5.71+50.7%	$3.79-55.0%	$8.42+124.5%	$3.75

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q4'23	Q3'24	Q2'24
Revenue	$5.5B+4.5%	$5.3B+0.3%	$5.3B+0.9%	$5.2B+3.0%	$5.1B-6.0%	$5.4B+6.5%	$5.1B-0.3%	$5.1B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	$853.0M-4.0%	$889.0M+8.0%	$823.0M-12.7%	$943.0M+14.9%	$821.0M+11.7%	$735.0M+29.4%	$568.0M-6.0%	$604.0M
Interest Expense	$205.0M-0.5%	$206.0M0.0%	$206.0M+1.0%	$204.0M+0.5%	$203.0M-10.6%	$227.0M0.0%	$227.0M+0.4%	$226.0M
Income Tax	$37.0M-72.2%	$133.0M+10.8%	$120.0M-16.1%	$143.0M+72.3%	$83.0M+31.7%	$63.0M-20.3%	$79.0M-1.3%	$80.0M
Net Income	$644.0M+11.2%	$579.0M+10.9%	$522.0M-16.1%	$622.0M+8.7%	$572.0M+25.4%	$456.0M+71.4%	$266.0M-9.2%	$293.0M
EPS (Diluted)	$4.22+9.3%	$3.86+22.9%	$3.14-26.5%	$4.27+12.7%	$3.79+64.8%	$2.30+144.7%	$0.94-18.3%	$1.15

THC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$29.7B+2.6%	$28.9B+2.2%	$28.3B+4.3%	$27.2B-1.5%	$27.6B+1.7%	$27.1B
Current Assets	$7.8B+2.2%	$7.7B+7.2%	$7.2B+19.8%	$6.0B-15.5%	$7.1B-1.0%	$7.1B
Cash & Equivalents	$2.9B-4.5%	$3.0B+145.8%	$1.2B+43.1%	$858.0M-63.7%	$2.4B-3.4%	$2.4B
Inventory	$348.0M+0.6%	$346.0M-15.8%	$411.0M+1.5%	$405.0M+5.5%	$384.0M+4.3%	$368.0M
Accounts Receivable	$2.6B+1.1%	$2.5B-13.0%	$2.9B-1.0%	$2.9B+6.2%	$2.8B+3.0%	$2.7B
Goodwill	$11.2B+4.7%	$10.7B+3.7%	$10.3B+1.8%	$10.1B+9.3%	$9.3B+5.1%	$8.8B
Total Liabilities	$20.7B+1.5%	$20.4B-10.6%	$22.8B+1.1%	$22.5B-3.3%	$23.3B-3.7%	$24.2B
Current Liabilities	$4.5B+3.5%	$4.3B-9.5%	$4.8B+6.3%	$4.5B-12.4%	$5.1B+5.4%	$4.8B
Long-Term Debt	$13.1B+0.1%	$13.1B-12.1%	$14.9B-0.3%	$14.9B-3.7%	$15.5B-0.4%	$15.6B
Total Equity	$4.2B+1.2%	$4.2B+159.4%	$1.6B+40.8%	$1.1B+11.1%	$1.0B+3571.4%	$28.0M
Retained Earnings	$4.4B+46.8%	$3.0B+1666.7%	-$192.0M+76.1%	-$803.0M+33.9%	-$1.2B+43.0%	-$2.1B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q4'23	Q3'24	Q2'24
Total Assets	$29.7B+0.9%	$29.4B+2.5%	$28.7B-1.8%	$29.2B+1.0%	$28.9B+2.2%	$28.3B+2.6%	$27.6B+1.6%	$27.2B
Current Assets	$7.8B+0.5%	$7.8B+7.0%	$7.3B-7.8%	$7.9B+3.0%	$7.7B+7.2%	$7.2B+12.7%	$6.4B+6.1%	$6.0B
Cash & Equivalents	$2.9B-3.1%	$3.0B+13.3%	$2.6B-12.5%	$3.0B-0.7%	$3.0B+145.8%	$1.2B+16.5%	$1.1B+12.8%	$934.0M
Inventory	$348.0M+0.6%	$346.0M+2.4%	$338.0M-1.7%	$344.0M-0.6%	$346.0M-15.8%	$411.0M-0.5%	$413.0M+2.2%	$404.0M
Accounts Receivable	$2.6B+1.9%	$2.5B-0.6%	$2.5B-3.3%	$2.6B+3.3%	$2.5B-13.0%	$2.9B+0.6%	$2.9B-0.6%	$2.9B
Goodwill	$11.2B+0.4%	$11.2B+2.0%	$10.9B+1.4%	$10.8B+0.9%	$10.7B+3.7%	$10.3B-1.0%	$10.4B+0.6%	$10.3B
Total Liabilities	$20.7B-0.1%	$20.7B+1.6%	$20.4B-0.9%	$20.6B+1.0%	$20.4B-10.6%	$22.8B+1.8%	$22.4B+1.1%	$22.2B
Current Liabilities	$4.5B-2.1%	$4.6B+6.8%	$4.3B-4.0%	$4.5B+3.3%	$4.3B-9.5%	$4.8B+7.4%	$4.4B+6.7%	$4.2B
Long-Term Debt	$13.1B-0.1%	$13.1B+0.1%	$13.1B+0.1%	$13.1B0.0%	$13.1B-12.1%	$14.9B-0.1%	$14.9B0.0%	$14.9B
Total Equity	$4.2B+5.1%	$4.0B+7.1%	$3.7B-10.3%	$4.2B+0.2%	$4.2B+159.4%	$1.6B+9.8%	$1.5B+9.0%	$1.3B
Retained Earnings	$4.4B+9.2%	$4.0B+9.2%	$3.7B+8.4%	$3.4B+13.5%	$3.0B+1666.7%	-$192.0M+56.0%	-$436.0M+18.8%	-$537.0M

THC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$3.5B+72.9%	$2.0B-13.8%	$2.4B+119.2%	$1.1B-30.9%	$1.6B-54.0%	$3.4B
Capital Expenditures	$1.0B+8.5%	$931.0M+24.0%	$751.0M-1.4%	$762.0M+15.8%	$658.0M+21.9%	$540.0M
Free Cash Flow	$2.5B+126.7%	$1.1B-31.2%	$1.6B+405.6%	$321.0M-64.7%	$910.0M-68.3%	$2.9B
Investing Cash Flow	-$1.3B-137.2%	$3.4B+453.9%	-$969.0M-19.9%	-$808.0M-13.2%	-$714.0M+55.6%	-$1.6B
Financing Cash Flow	-$2.4B+34.8%	-$3.7B-256.0%	-$1.0B+41.9%	-$1.8B-90.3%	-$936.0M-343.1%	$385.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$1.4B+106.3%	$672.0M+236.0%	$200.0M-20.0%	$250.0M	$0	$0

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q4'23	Q3'24	Q2'24
Operating Cash Flow	$731.0M-30.9%	$1.1B+13.0%	$936.0M+14.8%	$815.0M+346.2%	-$331.0M-140.2%	$824.0M+63.8%	$503.0M-15.9%	$598.0M
Capital Expenditures	$364.0M+30.0%	$280.0M+45.1%	$193.0M+11.6%	$173.0M-47.6%	$330.0M+58.7%	$208.0M+18.2%	$176.0M+33.3%	$132.0M
Free Cash Flow	$367.0M-52.8%	$778.0M+4.7%	$743.0M+15.7%	$642.0M+197.1%	-$661.0M-207.3%	$616.0M+88.4%	$327.0M-29.8%	$466.0M
Investing Cash Flow	-$389.0M-1.0%	-$385.0M-22.6%	-$314.0M-67.9%	-$187.0M+49.7%	-$372.0M-11.7%	-$333.0M-97.0%	-$169.0M+6.6%	-$181.0M
Financing Cash Flow	-$434.0M-34.4%	-$323.0M+67.6%	-$996.0M-53.7%	-$648.0M-74.2%	-$372.0M-17.4%	-$317.0M-48.1%	-$214.0M+14.1%	-$249.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$198.0M+112.9%	$93.0M-87.6%	$747.0M+114.7%	$348.0M	$0-100.0%	$110.0M	$0-100.0%	$40.0M

THC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	16.5%-12.4pp	28.8%+16.6pp	12.2%+0.0pp	12.2%-2.6pp	14.7%+3.4pp	11.3%
Net Margin	11.1%-8.5pp	19.7%+13.3pp	6.4%+1.2pp	5.2%-2.4pp	7.6%+3.2pp	4.3%
Return on Equity	56.1%-41.3pp	97.4%+15.9pp	81.5%-6.1pp	87.6%-55.9pp	143.6%-2599.3pp	2742.9%
Return on Assets	8.0%-6.1pp	14.0%+9.4pp	4.6%+0.9pp	3.7%-1.7pp	5.3%+2.5pp	2.8%
Current Ratio	1.76-0.0	1.78+0.3	1.51+0.2	1.34-0.0	1.38-0.1	1.47
Debt-to-Equity	3.10-0.0	3.14-6.1	9.26-3.8	13.08-2.0	15.09-541.1	556.21
FCF Margin	11.9%+6.5pp	5.4%-2.5pp	7.9%+6.2pp	1.7%-3.0pp	4.7%-11.6pp	16.3%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q4'23	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	15.4%-1.4pp	16.8%+1.2pp	15.6%-2.4pp	18.1%+1.9pp	16.2%+2.6pp	13.6%+2.4pp	11.2%-0.7pp	11.9%
Net Margin	11.7%+0.7pp	10.9%+1.0pp	9.9%-2.0pp	11.9%+0.6pp	11.3%+2.8pp	8.5%+3.2pp	5.3%-0.5pp	5.8%
Return on Equity	15.3%+0.8pp	14.4%+0.5pp	13.9%-1.0pp	14.9%+1.2pp	13.7%-14.7pp	28.4%+10.2pp	18.2%-3.7pp	21.8%
Return on Assets	2.2%+0.2pp	2.0%+0.1pp	1.8%-0.3pp	2.1%+0.1pp	2.0%+0.4pp	1.6%+0.7pp	1.0%-0.1pp	1.1%
Current Ratio	1.76+0.0	1.710.0	1.71-0.1	1.780.0	1.78+0.3	1.51+0.1	1.430.0	1.44
Debt-to-Equity	3.10-0.2	3.26-0.2	3.49+0.4	3.130.0	3.14-6.1	9.26-0.9	10.18-0.9	11.10
FCF Margin	6.6%-8.1pp	14.7%+0.6pp	14.1%+1.8pp	12.3%+25.3pp	-13.0%-24.4pp	11.4%+5.0pp	6.5%-2.7pp	9.2%

Similar Companies

Fresenius Med Cr FMS

$14.0B

Univ Health Svc UHS

$14.4B

Encompass Health Corp EHC

$10.7B

Hca Healthcare Inc HCA

$118.2B

Davita Inc DVA

$9.8B

Frequently Asked Questions

What is Tenet Healthcare Corp's annual revenue?

Tenet Healthcare Corp (THC) reported $21.3B in total revenue for fiscal year 2025. This represents a 3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Tenet Healthcare Corp's revenue growing?

Tenet Healthcare Corp (THC) revenue grew by 3.1% year-over-year, from $20.7B to $21.3B in fiscal year 2025.

Is Tenet Healthcare Corp profitable?

Yes, Tenet Healthcare Corp (THC) reported a net income of $2.4B in fiscal year 2025, with a net profit margin of 11.1%.

What is Tenet Healthcare Corp's earnings per share (EPS)?

Tenet Healthcare Corp (THC) reported diluted earnings per share of $15.49 for fiscal year 2025. This represents a -52.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Tenet Healthcare Corp's EBITDA?

Tenet Healthcare Corp (THC) had EBITDA of $4.4B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Tenet Healthcare Corp have?

As of fiscal year 2025, Tenet Healthcare Corp (THC) had $2.9B in cash and equivalents against $13.1B in long-term debt.

What is Tenet Healthcare Corp's operating margin?

Tenet Healthcare Corp (THC) had an operating margin of 16.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Tenet Healthcare Corp's net profit margin?

Tenet Healthcare Corp (THC) had a net profit margin of 11.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Tenet Healthcare Corp's return on equity (ROE)?

Tenet Healthcare Corp (THC) has a return on equity of 56.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Tenet Healthcare Corp's free cash flow?

Tenet Healthcare Corp (THC) generated $2.5B in free cash flow during fiscal year 2025. This represents a 126.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Tenet Healthcare Corp's operating cash flow?

Tenet Healthcare Corp (THC) generated $3.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Tenet Healthcare Corp's total assets?

Tenet Healthcare Corp (THC) had $29.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Tenet Healthcare Corp's capital expenditures?

Tenet Healthcare Corp (THC) invested $1.0B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Tenet Healthcare Corp buy back shares?

Yes, Tenet Healthcare Corp (THC) spent $1.4B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Tenet Healthcare Corp have outstanding?

Tenet Healthcare Corp (THC) had 87M shares outstanding as of fiscal year 2025.

What is Tenet Healthcare Corp's current ratio?

Tenet Healthcare Corp (THC) had a current ratio of 1.76 as of fiscal year 2025, which is generally considered healthy.

What is Tenet Healthcare Corp's debt-to-equity ratio?

Tenet Healthcare Corp (THC) had a debt-to-equity ratio of 3.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Tenet Healthcare Corp's return on assets (ROA)?

Tenet Healthcare Corp (THC) had a return on assets of 8.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Tenet Healthcare Corp's Altman Z-Score?

Tenet Healthcare Corp (THC) has an Altman Z-Score of 2.03, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Tenet Healthcare Corp's Piotroski F-Score?

Tenet Healthcare Corp (THC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Tenet Healthcare Corp's earnings high quality?

Tenet Healthcare Corp (THC) has an earnings quality ratio of 1.50x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Tenet Healthcare Corp cover its interest payments?

Tenet Healthcare Corp (THC) has an interest coverage ratio of 4.3x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Tenet Healthcare Corp?

Tenet Healthcare Corp (THC) scores 55 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.